Acter Technology Integration Group Co (SHSE:603163) Research & Development: ¥30 Mil (TTM As of Mar. 2026)


SHSE:603163 Acter Technology Integration Group Co Ltd SHSE:603163
75 GF Score
Price ¥125.40
GF Value ¥48.24
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Acter Technology Integration Group Co Research & Development?

Acter Technology Integration Group Co SHSE:603163 -3.24% 75 Research & Development is ¥30 Mil as of Mar. 2026. GuruFocus rates SHSE:603163 with a GF Score™ of 75/100 and a GF Value™ of ¥48.24 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Acter Technology Integration Group Co's Research & Development for the three months ended in Mar. 2026 was ¥7 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ¥30 Mil.

Acter Technology Integration Group Co  (SHSE:603163) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Acter Technology Integration Group Co Research & Development Related Terms

Acter Technology Integration Group Co Research & Development Historical Data

* Premium members only.

The historical data trend for Acter Technology Integration Group Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acter Technology Integration Group Co Research & Development Chart

Acter Technology Integration Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 13.18 19.10 25.12 33.53 31.25

Acter Technology Integration Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.53 5.56 12.67 4.50 7.40
SHSE:603163
75GF Score
Acter Technology Integration Group Co Ltd SHSE:603163
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acter Technology Integration Group Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥30 Mil mean?
Acter Technology Integration Group Co (SHSE:603163) has a Research & Development of ¥30 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Acter Technology Integration Group Co and its competitors.
Is Acter Technology Integration Group Co's Research & Development too high?
Acter Technology Integration Group Co's current Research & Development is ¥30 Mil. Overall, Acter Technology Integration Group Co has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Acter Technology Integration Group Co's Research & Development compare to PWR and FIX?
Acter Technology Integration Group Co's Research & Development of ¥30 Mil can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Construction company?
A good Research & Development depends on the Construction industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Acter Technology Integration Group Co and its competitors. Acter Technology Integration Group Co's current Research & Development is ¥30 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acter Technology Integration Group Co stock overvalued right now?
Based on GuruFocus' analysis, Acter Technology Integration Group Co (SHSE:603163) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥48.24, compared to a current price of ¥125.40 — trading 160% above its estimated fair value. The current Research & Development is ¥30 Mil. Acter Technology Integration Group Co's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Acter Technology Integration Group Co (SHSE:603163), the current Research & Development is ¥30 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acter Technology Integration Group Co (SHSE:603163) Overvalued in 2026?

Based on GuruFocus' analysis, Acter Technology Integration Group Co stock appears to be overvalued. The current stock price of ¥125.40 is trading 160% above its estimated GF Value™ of ¥48.24. GuruFocus considers Acter Technology Integration Group Co to be Significantly Overvalued.

Key valuation signals for SHSE:603163:

  • Research & Development: ¥30 Mil
  • GF Value™: ¥48.24 vs. price of ¥125.40 (160% above fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the SHSE:603163 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acter Technology Integration Group Co Business Description

Address No. 189, Shilin Road, Xushuguan Economic Development Zone, Suzhou High-tech Zone, Jiangsu Province, Suzhou, CHN, 215151
Acter Technology Integration Group Co Ltd is a professional service provider in China's cleanroom industry, offering comprehensive cleanroom system integration engineering solutions. Its business encompasses cleanroom plant construction planning, design advice, equipment configuration, engineering construction, project management, and maintenance services.
75GF Score

Get the complete analysis for SHSE:603163

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥125.40
Price
¥48.24
GF Value